1. Dergilev KV, Komova AV, Tsokolaeva ZI, Beloglazova IB, Parfyonova YeV. Epicardium as a new target for regenerative technologies in cardiology. Geny Kletki. 2020;15(2):33-40. Russian.
2. Dergilev KV, Tsokolaeva ZI, Beloglazova IB, Ratner EI, Molokotina YuD, Parfenova EV. Angiogenic properties of myocardial c-kit+ cells. Geny Kletki. 2018;13(3):82-88. Russian.
3. Sergienko IV, Semenova AE, Masenko VP, Habibullina LI Gabrusenko SA, Kukharchuk VV, Belenkov YuN. Myocardial revascularization effects on vascular endothelial growth factor and transforming growth factor β-1 in coronary heart disease patients. Kardiovask. Ter. Prof. 2007;6(5):12-17. Russian.
4. Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes DK, Raines EW, Ross R, Sporn MB. Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc. Natl Acad. Sci. USA. 1987;84(17):6020-6024.
5. Burns WC, Thomas MC. The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology. Expert Rev. Mol. Med. 2010;12:e17. doi: https://doi.org/10.1017/S1462399410001481